期刊文献+

140所医院ICU医院感染病原菌分布及耐药性分析 被引量:5

Distribution and drug resistance of pathogens causing nosocomial infections in ICU of 140 hospitals
原文传递
导出
摘要 目的通过对ICU进行目标性监测,了解ICU住院患者医院感染病原菌的分布及耐药性,提出控制措施。方法回顾性统计分析2011年1-12月入住ICU患者医院感染常见病原菌及耐药性,进行。结果 1年中全省140所医院所有医院感染病例共获得各种病原菌10765株,以革兰阴性杆菌为主6864株占63.76%,革兰阳性菌明显减少仅有2566株占23.84%,真菌1335株占12.4%;检出病原菌对临床常用抗菌药物均有不同程度的耐药性,多药耐药呈增加趋势。结论降低ICU医院感染发生率,减少ICU医院感染病原菌的增加,合理使用抗菌药物是今后医院感染工作的重要内容。 OBJECTIVE To perform the targeted monitoring of the ICU and understand the distribution and drug resistance of the pathogens isolated from the hospitalized patients in ICU so as to put forward the control measures.METHODS The common pathogens causing nosocomial infections in the patients who enrolled the ICU from Jan to Dec 2011 were statistically analyzed,the drug resistance was observed.RESULTS A total of 10 765 strains of pathogens were isolated from 140 hospitals within one year,among which there were 6864(63.76%) strains of gram-negative bacilli,2566(23.84%) strains of gram-positive bacteria,and 1335(12.4%) strains of fungi.The isolated pathogens varied in the drug resistance to the commonly used antibiotics.The multidrug-resistant bacteria kept an increasing upward tendency.CONCLUSION It is crucial to the infection control to reduce the incidence of nosocomial infections in ICU,decrease the pathogens causing nosocomial infections,and use antibiotics reasonably.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2012年第21期4900-4902,共3页 Chinese Journal of Nosocomiology
关键词 重症监护病房 医院感染 病原菌 耐药性 Intensive care unit Nosocomial infection Pathogen Drug resistance
  • 相关文献

参考文献9

二级参考文献70

共引文献915

同被引文献45

  • 1史文元,吴意,吴志坚,李胜涛,徐桂珍,徐玉娟.常见非发酵革兰氏阴性杆菌的分布与耐药特性分析[J].世界临床医学,2017,11(5):227-228. 被引量:4
  • 2张冀霞,陈宏斌,王辉,徐英春,陈民钧,张嵘,刘文恩,徐修礼,曹彬,宁永忠,廖康,褚云卓,胡志东,曾吉,王勇,苏丹虹,周春妹,李丽红,邹明祥,杨佩红,刘颖梅,陈冬梅,年华,田彬,熊艳,李平,卓超,谢红梅.2007年和2009年医院内获得性血流感染病原菌分布及其耐药性分析[J].中华临床医师杂志(电子版),2012,6(19):5935-5942. 被引量:22
  • 3李晓红,虞德才,左改珍,陈义芬,张炳新,鲁朝辉.1132例住院患者抗菌药物使用率横断面调查[J].中华医院感染学杂志,2006,16(6):684-686. 被引量:44
  • 4Fournier P, Schwebel C, Maubon D, et al. Antifungal use influences Candida species distribution and susceptibility in the intensive care unit[J]. J Antimierob Chemother, 2011,66 (12) :2880- 2886.
  • 5Meyer E, Gastmeier P, Deja M, et al. Antibiotic consumption and resistance: data from Europe and Germany[J]. Int J Med Mierobiol,2013, 303(6-7) :388-395.
  • 6Zarb P, Coignard B, Griskevieiene J, et al. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healtheare associated infections and antimicrobial use[J].Euro Surveill,2012,17(46) : 20316.
  • 7Garnacho Montero J, Ortiz-Leyba C, Herrera-Melero I, et al. Mortality and morbidity attributable to inadequate empirical antimierobial therapy in patients admitted to the ICU with sepsis: a matched cohort study[J]. J Antimicrob Chemother, 2008,61 (2) : 436 -441.
  • 8Shafazand S, Weinacker AB. Blood cultures in the critical care unit: improving utilization and yield[J]. Chest, 2002, 122(5):1727 -1736.
  • 9Kaye KS. Antimicrobial de-escalation strategies in hospitalized patients with pneumonia, intra-abdominal infections, and bacteremia[J]. J Hosp Med, 2012,7 (Suppl 1 ) : s13 -s21.
  • 10Khasawneh FA, Karim A, Mahmood T, et al. Safety and feasibility of antibiotic de escalation in bacteremic pneumonia [J]. Infect Drug Resist, 2014,7:177- 182.

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部